BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

332 related articles for article (PubMed ID: 37055777)

  • 1. Predicting long-term prognosis after percutaneous coronary intervention in patients with new onset ST-elevation myocardial infarction: development and external validation of a nomogram model.
    Ye Z; Xu Y; Tang L; Wu M; Wu B; Zhu T; Wang J
    Cardiovasc Diabetol; 2023 Apr; 22(1):87. PubMed ID: 37055777
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Establishment and validation of a risk model for prediction of in-hospital mortality in patients with acute ST-elevation myocardial infarction after primary PCI.
    Gao N; Qi X; Dang Y; Li Y; Wang G; Liu X; Zhu N; Fu J
    BMC Cardiovasc Disord; 2020 Dec; 20(1):513. PubMed ID: 33297955
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development and validation of a prognostic model for predicting post-discharge mortality risk in patients with ST-segment elevation myocardial infarction (STEMI) undergoing primary percutaneous coronary intervention (PPCI).
    Zhang L; Liu Z; Zhu Y; Wu M; Huang H; Yang W; Peng K; Zeng J
    J Cardiothorac Surg; 2024 Mar; 19(1):163. PubMed ID: 38555468
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multimodal data-driven prognostic model for predicting new-onset ST-elevation myocardial infarction following emergency percutaneous coronary intervention.
    Tang L; Wu M; Xu Y; Zhu T; Fang C; Ma K; Wang J
    Inflamm Res; 2023 Sep; 72(9):1799-1809. PubMed ID: 37644338
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Construction and evaluation of nomogram model for individualized prediction of risk of major adverse cardiovascular events during hospitalization after percutaneous coronary intervention in patients with acute ST-segment elevation myocardial infarction.
    Fang C; Chen Z; Zhang J; Jin X; Yang M
    Front Cardiovasc Med; 2022; 9():1050785. PubMed ID: 36620648
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Predictive Model for Contrast-Induced Acute Kidney Injury After Percutaneous Coronary Intervention in Elderly Patients with ST-Segment Elevation Myocardial Infarction.
    Qiu H; Zhu Y; Shen G; Wang Z; Li W
    Clin Interv Aging; 2023; 18():453-465. PubMed ID: 36987461
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Predictive value of triglyceride glucose index combined with neutrophil-to-lymphocyte ratio for major adverse cardiac events after PCI for acute ST-segment elevation myocardial infarction.
    Wang L; Wang Y; Wang W; Wang Z
    Sci Rep; 2024 Jun; 14(1):12634. PubMed ID: 38824158
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High triglyceride-glucose index is associated with poor prognosis in patients with acute ST-elevation myocardial infarction after percutaneous coronary intervention.
    Luo E; Wang D; Yan G; Qiao Y; Liu B; Hou J; Tang C
    Cardiovasc Diabetol; 2019 Nov; 18(1):150. PubMed ID: 31722708
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic Nutritional Index Combined with Triglyceride-Glucose Index to Contrast a Nomogram for Predicting Contrast-Induced Kidney Injury in Type 2 Diabetes Mellitus Patients with Acute Coronary Syndrome After Percutaneous Coronary Intervention.
    Zhu Y; He H; Qiu H; Zhang X; Wang L; Li W
    Clin Interv Aging; 2023; 18():1663-1673. PubMed ID: 37810953
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Nomogram Based on Apelin-12 for the Prediction of Major Adverse Cardiovascular Events after Percutaneous Coronary Intervention among Patients with ST-Segment Elevation Myocardial Infarction.
    Zhao E; Xie H; Zhang Y
    Cardiovasc Ther; 2020; 2020():9416803. PubMed ID: 32099583
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development of a nomogram for the prediction of in-hospital mortality in patients with acute ST-elevation myocardial infarction after primary percutaneous coronary intervention: a multicentre, retrospective, observational study in Hebei province, China.
    Wang Y; Wang W; Jia S; Gao M; Zheng S; Wang J; Dang Y; Li Y; Qi X
    BMJ Open; 2022 Feb; 12(2):e056101. PubMed ID: 35110324
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Establishment and validation of nomogram model for predicting major adverse cardiac events in patients with acute ST-segment elevation myocardial infarction based on glycosylated hemoglobin A1c to apolipoprotein A1 ratio: An observational study.
    Zhang KP; Guo QC; Mu N; Liu CH
    Medicine (Baltimore); 2024 Jun; 103(24):e38563. PubMed ID: 38875361
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Triglyceride glucose index combined with plaque characteristics as a novel biomarker for cardiovascular outcomes after percutaneous coronary intervention in ST-elevated myocardial infarction patients: an intravascular optical coherence tomography study.
    Zhao X; Wang Y; Chen R; Li J; Zhou J; Liu C; Zhou P; Sheng Z; Chen Y; Song L; Zhao H; Yan H
    Cardiovasc Diabetol; 2021 Jun; 20(1):131. PubMed ID: 34183007
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of triglyceride-glucose index on intracoronary thrombus burden in ST-elevation myocardial infarction patients undergoing primary percutaneous coronary intervention.
    Köktürk U; Önalan O; Somuncu MU; Akgül Ö; Uygur B; Püşüroğlu H
    Nutr Metab Cardiovasc Dis; 2024 Apr; 34(4):860-867. PubMed ID: 38336545
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A prognostic nomogram for long-term major adverse cardiovascular events in patients with acute coronary syndrome after percutaneous coronary intervention.
    Kong S; Chen C; Zheng G; Yao H; Li J; Ye H; Wang X; Qu X; Zhou X; Lu Y; Zhou H
    BMC Cardiovasc Disord; 2021 May; 21(1):253. PubMed ID: 34022791
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The predictive value of the nomogram model of clinical risk factors for ischemia-reperfusion injury after primary percutaneous coronary intervention.
    Wang Z; Peng J
    Sci Rep; 2023 Mar; 13(1):5084. PubMed ID: 36977721
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development and validation of a risk prediction nomogram for in-stent restenosis in patients undergoing percutaneous coronary intervention.
    He W; Xu C; Wang X; Lei J; Qiu Q; Hu Y; Luo D
    BMC Cardiovasc Disord; 2021 Sep; 21(1):435. PubMed ID: 34521385
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development and Validation of a Risk Nomogram Model for Predicting Contrast-Induced Acute Kidney Injury in Patients with Non-ST-Elevation Acute Coronary Syndrome Undergoing Primary Percutaneous Coronary Intervention.
    Ma K; Li J; Shen G; Zheng D; Xuan Y; Lu Y; Li W
    Clin Interv Aging; 2022; 17():65-77. PubMed ID: 35115770
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A nomogram risk prediction model for no-reflow after primary percutaneous coronary intervention based on rapidly accessible patient data among patients with ST-segment elevation myocardial infarction and its relationship with prognosis.
    Liu Y; Ye T; Chen K; Wu G; Xia Y; Wang X; Zong G
    Front Cardiovasc Med; 2022; 9():966299. PubMed ID: 36003914
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A radiomic nomogram for prediction of major adverse cardiac events in ST-segment elevation myocardial infarction.
    Ma Q; Ma Y; Wang X; Li S; Yu T; Duan W; Wu J; Wen Z; Jiao Y; Sun Z; Hou Y
    Eur Radiol; 2021 Feb; 31(2):1140-1150. PubMed ID: 32856164
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.